News & Media
Novavax to Participate in the Citi 12th Annual Biotech Conference
Sep 5, 2017

GAITHERSBURG, Md.Sept. 05, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) today announced the Company will participate in Citi’s 12th Annual Biotech Conference.

Conference details are as follows:

Date: Thursday, September 7, 2017
Location: Mandarin Oriental hotel, Boston, MA

About Novavax

Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Our recombinant nanoparticles and Matrix-M™ adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines. Additional information about Novavax is available on the Company's website,


Investor Relations
Novavax, Inc.Andrea N. Flynn, Ph.D.
Director, Investor Relations

Westwicke Partners
John Woolford

Russo Partners, LLC
David Schull
Maggie Beller